Leisure sitting time associated with increased risk of cancer in women
the ONA take:
According to a study published in the journal Cancer Epidemiology, Biomarkers & Prevention, researchers have found that spending more leisure time sitting was associated with an increased risk for developing cancer in women.
For the study, researchers analyzed data from more than 146,000 men and women included in the American Cancer Society Cancer Prevention Study II Nutrition Cohort to compare leisure time sitting with cancer risk. Of the 77,462 women and 69,260 men, 12,236 women and 18,555 men were diagnosed with cancer between 1992 and 2009.
Results showed that leisure time sitting was associated with a 10% increased risk for developing cancer in women after adjusting for confounding factors, such as body mass index, physical activity, and other factors. Researchers found no association between sitting time and cancer risk in men.
The study demonstrated that sitting time was associated with an increased risk for developing invasive breast cancer, multiple myeloma, and ovarian cancer in women.
The authors note that further research is warranted to better understand the differences in associations of sitting time and cancer risk between men and women.
Researchers have found that spending more leisure time sitting was associated with an increased risk for developing cancer in women.
Sign Up for Free e-newsletters
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|